Los Angeles Capital Management LLC Opti Nose, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.2 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$2.91 - $3.83 $7,857 - $10,341
-2,700 Reduced 5.43%
47,065 $146,000
Q1 2021

May 05, 2021
BUY
$3.47 - $4.75 $172,684 - $236,383
49,765 New
49,765 $183,000

Others Institutions Holding OPTN

# of Institutions
9
Shares Held
52.9M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $500M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email